Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.